Intimacy · Reference
Kisspeptin vs Oxytocin: Hormone Axis vs Bonding Hormone, Evidence, Dosing and Cost
This page explains each on its own terms, puts them side by side, covers what the research does and does not show, where each stands with the FDA, how each is dosed, what each costs at Pepti, and who tends to suit which.
Treatments mentioned
Kisspeptin and oxytocin are both natural hormones prescribed around intimacy, but they work at different points: kisspeptin acts upstream on the reproductive hormone axis and the brain's sexual processing, while oxytocin acts on the experience of intimacy itself and has no effect on reproductive hormone output. Kisspeptin's randomised trials, using the related kisspeptin-54 by infusion, measured brain activation and physiological arousal in people with low desire. Oxytocin's randomised trials, all by nasal spray, found effects on orgasm intensity and contentment after sex in couples, no effect on desire or arousal, and a null result in women with sexual dysfunction. Both are prescription-only, compounded by a licensed US pharmacy, and neither compounded product is FDA approved.
This page explains each on its own terms, puts them side by side, covers what the research does and does not show, where each stands with the FDA, how each is dosed, what each costs at Pepti, and who tends to suit which.
Kisspeptin vs Oxytocin
The short answer
| If your main goal is | The usual prescription | What is in it | Price |
|---|---|---|---|
| Desire, with a hormonal mechanism behind it | Kisspeptin | 10 mg kisspeptin-10 in a 5 mL vial (2 mg/mL) | $229/mo |
| The experience of intimacy and connection | Oxytocin | 10 mg oxytocin in a 5 mL vial (2 mg/mL) | $239/mo |
| Desire and connection together | PT-141 + Oxytocin | 10 mg PT-141 and 5 mg oxytocin in a 5 mL vial | $259/mo |
| Desire and arousal, the most established option | PT-141 | 10 mg PT-141 (bremelanotide) in a 5 mL vial | $259/mo |
| Kisspeptin alongside recovery and energy components | EUPHORIA Blend | MOTS-c, BPC-157, GHK-Cu and kisspeptin-10 | $279/mo |
Every figure is an all-in monthly price covering the medication, physician review, refill management and shipping. There is no separate membership fee. Current pricing always lives on each product page; the table is a guide to which product fits which goal.
Kisspeptin vs Oxytocin
Kisspeptin on its own terms
What it is
Kisspeptin is a family of peptides from the KISS1 gene. The full-length hormone, kisspeptin-54, and shorter fragments share a ten-amino-acid tail that binds the receptor KISS1R. The Pepti product is kisspeptin-10, the shortest active form. The gene was found in 1996 in Hershey, Pennsylvania, as a suppressor of melanoma spread and named after the town's chocolate; its reproductive role was recognised in 2003, when people born without a working KISS1R were found not to go through puberty. The full reference is at what is kisspeptin.
How kisspeptin is described to work
- Starting the reproductive axis. Kisspeptin acts on the neurons that make gonadotropin-releasing hormone (GnRH), which tells the pituitary to release LH and FSH, which in turn drive testosterone, oestrogen and ovulation. Intravenous kisspeptin raised LH, FSH and testosterone in healthy men within the hour (2005 and 2011, Journal of Clinical Endocrinology and Metabolism).
- Limbic brain activity. A 2017 functional MRI study in the Journal of Clinical Investigation reported greater activation of emotion and reward regions in response to sexual and couple-bonding images during a kisspeptin-54 infusion, with reduced negative mood.
- Gaps matter. The response fades under continuous exposure and holds up when exposure is spaced, a pattern called tachyphylaxis. That is why the schedule includes days off.
What human data exists for kisspeptin
Study Who What was reported 2014, Journal of Clinical Investigation Women undergoing IVF A single kisspeptin-54 injection triggered egg maturation in the large majority 2022, JAMA Network Open Premenopausal women with low sexual desire disorder, randomised crossover Greater activation in sexual-processing brain regions during infusion 2023, JAMA Network Open Men with low sexual desire disorder, randomised crossover Greater brain activation to sexual stimuli and increased penile tumescence versus placebo There are no randomised trials of a subcutaneous kisspeptin-10 course over weeks, which is how it is prescribed.
Kisspeptin vs Oxytocin
Oxytocin on its own terms
What it is
Oxytocin is a nine-amino-acid hormone made in the hypothalamus and released from the posterior pituitary. It drives contractions in labour, triggers milk release during breastfeeding, and is released during sexual activity: a 1987 paper in the Journal of Clinical Endocrinology and Metabolism measured it rising during arousal and peaking around orgasm in both sexes. Unlike most compounded peptides, it is not a research compound; an oxytocin injection has been an FDA-approved hospital drug for decades. The full reference is at what is oxytocin.
The "bonding hormone" label
The label came from animal research, mostly in prairie voles, a monogamous rodent, showing that oxytocin signalling in the brain was needed for pair-bonding. A 2005 study in Nature reported that a nasal dose increased trust in an economic game; many later behavioural studies did not replicate at the same size. The popular name overstates what is known in people.
The delivery problem
Oxytocin clears from the blood in minutes and crosses into the brain poorly. A 2016 paper in Biological Psychiatry argued that the amount of sprayed oxytocin reaching the brain is uncertain. That critique applies at least as strongly to an injection, which has no nose-to-brain pathway.
What human data exists for oxytocin
Study Who What was reported 2014, Hormones and Behavior 29 healthy couples, nasal spray, double-blind crossover No change in drive, arousal, erection or lubrication; higher orgasm intensity and contentment afterwards; small to moderate effects 2015, Fertility and Sterility 30 women with sexual dysfunction, nasal spray, randomised crossover Both oxytocin and placebo groups improved; no significant difference 2009, Psychoneuroendocrinology 25 people with social anxiety, alongside therapy Better self-ratings; same overall outcome as placebo 2021, New England Journal of Medicine 290 children and adolescents with autism, 24 weeks No difference from placebo Every one used the nasal route. There are no randomised trials of subcutaneous oxytocin for intimacy, mood or social function.
Kisspeptin vs Oxytocin
Head to head
| Kisspeptin | Oxytocin | |
|---|---|---|
| What it is | The kisspeptin-10 fragment of a reproductive hormone | A nine-amino-acid pituitary hormone |
| Where it acts | Top of the reproductive axis, plus limbic brain regions | Oxytocin receptors in the reproductive tract, breast and brain |
| Effect on sex hormones | Prompts LH, FSH and testosterone release | None on reproductive hormone output |
| What trials looked at | Brain activation and arousal in low desire | Orgasm, contentment and partner interaction |
| Effect on desire in trials | Brain and physiological response increased (kisspeptin-54) | No effect on drive or arousal |
| Route in the trials | Mostly intravenous kisspeptin-54 | Nasal spray only |
| FDA-approved product of the molecule | None | Yes, a hospital injection for labour and postpartum bleeding |
| Typical directions at Pepti | 0.25 mL (25 units) once daily, Monday to Friday | 0.18 mL (18 units) once daily |
| Amount per dose | 0.5 mg (500 mcg) | 0.36 mg (360 mcg) |
| Price at Pepti | $229 a month | $239 a month |
The real difference is upstream versus in the moment
A simple way to put it: if the picture is hormonal, kisspeptin is the closer fit; if hormones are normal and the concern is the intimate experience itself, oxytocin is the more direct conversation. Kisspeptin works by prompting the body's own hormone axis and on how the brain processes sexual cues. Oxytocin's best trial found changes in how sex felt afterwards, not in wanting it. Neither has been compared with the other.
Kisspeptin vs Oxytocin
Who suits which
Kisspeptin
Kisspeptin suits someone interested in desire where the reproductive hormone axis may be part of the picture, who is not on testosterone therapy. More detail: kisspeptin benefits, kisspeptin dosage and kisspeptin for women.
Oxytocin
Oxytocin suits someone whose concern is closeness, relaxation or the intensity of the experience rather than desire or arousal, who understands the trial evidence is nasal, mixed, and has not been reproduced by injection.
PT-141, or PT-141 with oxytocin
When low desire or arousal is the main problem, PT-141 has randomised trials in low sexual desire disorder behind its active, bremelanotide. PT-141 + Oxytocin pairs the two because prescribers often want one aimed at desire and the other at the experience. See what is PT-141 + Oxytocin and kisspeptin vs PT-141.
Can you take kisspeptin and oxytocin together?
They act on different systems and have no known interaction, but no study has tested the combination. Your physician sets your directions after reviewing your intake.
Kisspeptin vs Oxytocin
When neither is the right first step
| Situation | What makes more sense |
|---|---|
| Low testosterone, thyroid problems or perimenopause | A look at the cause; these produce sexual symptoms neither peptide addresses |
| Erectile problems | A physician conversation about established treatments; oxytocin did not change erection in the couples trial |
| Already on testosterone therapy | Tell your physician; it suppresses the axis kisspeptin acts on |
| Anxiety is the main problem | Selank or the SERENITY Blend; the oxytocin anxiety trial was null |
| Trying to conceive | A reproductive endocrinologist |
Kisspeptin vs Oxytocin
Where each stands with the FDA
| Kisspeptin-10 | Oxytocin | |
|---|---|---|
| The molecule | Not approved for anything | An FDA-approved drug substance (hospital injection for labour and postpartum bleeding) |
| 503A position | Category 2 since 29 September 2023, still there on the list updated 14 May 2026 | Does not depend on the bulks list, because it has a USP monograph and is a component of an approved drug |
| Advisory committee | 29 October 2024: 0 for, 11 against, for secondary hypogonadism in men | Not applicable |
| The compounded product | Not FDA approved | Not FDA approved; intimacy is not an approved use of any oxytocin product |
Category 2 is an interim policy position, not a ban on the molecule, and the FDA has issued no final rule on kisspeptin-10. Compounded medications are not FDA approved. Are peptides FDA approved explains the difference between not approved and not legal.
Kisspeptin vs Oxytocin
Dosing, side by side
Both are injected under the skin (subcutaneously) into the abdomen or thigh, rotating sites. Both vials are 2 mg/mL. The figures are arithmetic on the vial strength, on a U-100 insulin syringe where 1 unit is 0.01 mL:
| Kisspeptin | Oxytocin | |
|---|---|---|
| Vial | 5 mL at 2 mg/mL (10 mg kisspeptin-10) | 5 mL at 2 mg/mL (10 mg oxytocin) |
| Printed directions | Inject 0.25 mL (25 units) subcutaneously once daily Monday through Friday | Inject 0.18 mL (18 units) subcutaneously once daily |
| Per dose | 0.25 mL x 2 mg/mL = 0.5 mg (500 mcg) | 0.18 mL x 2 mg/mL = 0.36 mg (360 mcg) |
| Doses per vial | 5 mL / 0.25 mL = 20 | 5 mL / 0.18 mL = 27 whole doses |
| How long a vial lasts | 20 weekday doses, about 4 weeks | 27 daily doses, just under 4 weeks |
The syringe units on a compounded oxytocin vial are a volume mark, not the USP units of activity printed on the hospital product; the two are not interchangeable. Your directions are printed on the vial, and your physician sets them after reviewing your intake. Both ship refrigerated with ice packs, sterile syringes and alcohol prep pads, and refills run every 28 days, one vial per fill.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Kisspeptin vs Oxytocin
Side effects
Kisspeptin. Kisspeptin-54 was described as well tolerated across the Imperial College studies, and the desire trials reported no serious adverse events attributed to it. Clinically: injection-site redness or soreness, brief flushing, headache, occasional nausea. A hormone-sensitive condition, including a history of hormone-sensitive cancer, must be raised first. More: kisspeptin side effects.
Oxytocin. In the controlled nasal trials, adverse events did not differ from placebo; the paediatric trial listed thirst, more frequent urination and constipation. With the injection, prescribers mostly hear about injection-site redness or soreness and occasional brief flushing or headache. Oxytocin contracts the uterus, which is why it must not be used in pregnancy outside a hospital, and at large intravenous obstetric doses the approved label warns of water retention and low blood pressure, so heart or fluid-balance conditions should be raised at intake.
For both, stop and contact your care team for any reaction that is severe or spreading. Difficulty breathing or swelling of the face or throat needs emergency care: call 911.
Kisspeptin vs Oxytocin
Who should not take either, or should discuss it first
| Situation | Why |
|---|---|
| Pregnancy or breastfeeding | Not used; oxytocin contracts the uterus, and kisspeptin safety data is absent |
| Hormone-sensitive condition or cancer | Especially for kisspeptin |
| On testosterone therapy | Especially for kisspeptin |
| Heart or fluid-balance condition | Especially for oxytocin |
| Tested athletes | Check your sport's current prohibited list before starting |
Kisspeptin vs Oxytocin
What the evidence shows, honestly
Kisspeptin's physiology is mapped in people, and its desire trials are randomised, but they used kisspeptin-54 by infusion in single sessions rather than the subcutaneous kisspeptin-10 course that is prescribed. Oxytocin has more randomised human trials than almost any compounded peptide, and they point in more than one direction: a small-to-moderate effect on the experience of sex in healthy couples, a null trial in women with a diagnosis, and a null large trial in autism, all by nasal spray. Neither has been shown in a trial to improve intimacy in daily life as prescribed.
Kisspeptin vs Oxytocin
Where to get kisspeptin or oxytocin prescribed
Neither can be bought legitimately without a prescription. Sites selling them "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your care team stays reachable for questions and side effects.
Pepti is cash-pay and does not bill insurance. Step-by-step: how to get kisspeptin prescribed online. Oxytocin pricing and details are on the oxytocin page.
References
What this is based on.
References
- Behnia B, Heinrichs M, Bergmann W et al.. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples · Horm Behav (2014) · PMID 24503174
- IsHak WW, Berman DS, Peters A. Male anorgasmia treated with oxytocin · J Sex Med (2008) · PMID 18086171
- Burri A, Heinrichs M, Schedlowski M, Kruger TH. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males · Psychoneuroendocrinology (2008) · PMID 18375074
- Muin DA, Wolzt M, Marculescu R et al.. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial · Fertil Steril (2015) · PMID 26151620
- Carmichael MS, Humbert R, Dixen J et al.. Plasma oxytocin increases in the human sexual response · J Clin Endocrinol Metab (1987) · PMID 3782434
- Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans · Nature (2005) · PMID 15931222
- Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder · Psychoneuroendocrinology (2009) · PMID 19246160
- Sikich L, Kolevzon A, King BH et al.. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder · N Engl J Med (2021) · PMID 34644471
- Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA, Guastella AJ. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial · Mol Psychiatry (2016) · PMID 26503762
- Ooi YP, Weng SJ, Kossowsky J, Gerger H, Sung M. Oxytocin and Autism Spectrum Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · Pharmacopsychiatry (2017) · PMID 27574858
- Leng G, Ludwig M. Intranasal Oxytocin: Myths and Delusions · Biol Psychiatry (2016) · PMID 26049207
- Walum H, Waldman ID, Young LJ. Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies · Biol Psychiatry (2016) · PMID 26210057
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Kisspeptin vs Oxytocin, answered.
Kisspeptin starts the reproductive hormone axis and acts on the brain's sexual processing. Oxytocin acts on the reproductive tract and brain around intimacy and has no effect on reproductive hormone output. Both are hormones the body makes.
For desire, kisspeptin has the more relevant trials: two small randomised studies of kisspeptin-54 in people with low desire measured increased brain and physiological responses. Oxytocin's couples trial found no effect on desire or arousal. Neither has been compared with the other.
No. Oxytocin has no effect on reproductive hormone output. Kisspeptin prompts the body's own axis, and single intravenous doses raised LH and testosterone in healthy men.
No study has tested the combination, and there is no established interaction list. Your physician sets your directions after reviewing your intake.
Same molecule, different product. The approved hospital injection is labelled in USP units for intravenous or intramuscular use in labour and after birth. The compounded vial is 2 mg/mL for subcutaneous injection, off-label, and not an approved product.
The prescribing and the pharmacy's preparation are built around injection. The trial evidence is for the nasal route and has not been reproduced by injection.
At Pepti, kisspeptin is $229 a month and oxytocin is $239 a month, all-in, including the medication, physician review, refill management and shipping. PT-141 + Oxytocin in one vial is $259 a month.
Pepti's typical printed directions are 0.25 mL (25 units) of kisspeptin once daily Monday through Friday, which is 0.5 mg, and 0.18 mL (18 units) of oxytocin once daily, which is 0.36 mg. Your own directions are printed on the vial.
The compounded products are not; compounded medications are not FDA approved. Oxytocin the molecule is in an FDA-approved hospital injection for labour. Kisspeptin-10 has no approved product and remains in the FDA's Category 2.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.